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B-cell commitment: Pax5 is the deciding factor 
Tariq Enver
Recent studies have identified the transcription factor
Pax5 as a critical determinant of commitment to the 
B-lymphocyte pathway. Surprisingly, Pax5 appears to
achieve this primarily through suppressing alternative
haematopoietic lineage fates.
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Selecting a cell lineage from two or more possibilities
represents a fundamental, and unavoidable, develop-
mental decision associated with the multicellular state of
the metazoa. The vertebrate haematopoietic system has
provided a key model system in which to examine the
mechanisms underlying such lineage commitment deci-
sions. Many candidate molecular players in the
haematopoietic lineage game have been identified but,
when tested using gene knockout approaches in mice,
have apparently failed to alter commitment decisions
[1]. That was at least until now. B cells lacking the tran-
scription factor Pax5 cannot complete all the stages of B-
cell differentiation. Nevertheless they appear, to all
intents and purposes, to represent authentic immature B
lymphocytes, termed pro-B cells, that are stalled at a
very early stage of development. Busslinger and col-
leagues [2,3] now show that these ostensibly committed
cells are nothing of the sort. Though superficially mas-
querading as B lymphocytes, these Pax5-deficient cells
exhibit many of the molecular and functional character-
istics of uncommitted multipotential stem cells and, in
fact, can differentiate down a number of other
haematopoietic lineages. So Pax5 apparently commits
cells to a B-cell fate by closing the door on other poten-
tial cell fates. It would seem that in the age-old dilemma
of to B or not to B, Pax5 is the deciding factor.
There are two major lineage commitment issues that
surround the blood system (Figure 1). The first con-
cerns how haematopoietic stem cells themselves are
generated from embryonic mesoderm during ontogeny.
The second relates to how the resulting pluripotent
haematopoietic stem cells undergo the commitment
processes that give rise to the multiple cell lineages that
constitute the blood. It is superficially tempting to con-
sider that these processes occur by similar mechanisms.
The biological imperatives of these two commitment
processes are quite different, however, and thus may
place quite distinct constraints on the underlying mole-
cular machinery. Ontogeny is in some senses a ‘one-off’
event, and there is no reason to think that the formation
of blood tissues during embryogenesis is in principle
controlled substantially differently from that of any
other tissue type. Indeed, from what we know so far, it
would seem that the specification of blood from meso-
derm is regulated by many of the same positional cues
that dorso-ventrally pattern the mesoderm and gener-
ate other mesodermal derivatives, such as muscle and
vascular endothelium [1].
Once formed during ontogeny, these haematopoietic
stem cells must service a lifetime’s supply of blood.
When we consider that the turnover of cells in the adult
human blood system is in the order of one trillion cells
per day, it is easy to see that the scale of the problem is
formidable. And it is made no less daunting by the fact
that stem cell numbers are themselves very small, and
only a handful of stem cells are thought to contribute to
haematopoiesis at any given moment. A critical feature
of haematopoietic stem cells, therefore, is their ability to
sustain their numbers — a process termed self-renewal
— while still servicing the requirement for differentiated
cells [4]. Striking a balance between self-renewal and
differentiation, as well as between the alternative stem
cell options of dormancy and apoptosis, is quite a tall
order. So how is it achieved?
Since lineage restriction presumably entails the forma-
tion of stable transcription complexes that elaborate
lineage-specific programmes of gene expression, we can
be reasonably confident that transcription factors have
something to do with the whole process. Many candidate
transcription factors have been identified by either their
expression profiles, their ability to bind to key cis-acting
regulatory elements of lineage-affiliated genes or their
association with leukaemia. The roles of many of these
factors in haematopoiesis have been illuminated by
knockout experiments in mice [1]. These experiments
have primarily identified the particular developmental
level or cellular stage at which the activity of a given tran-
scription factor first becomes critical. In some instances,
there have been striking effects on given lineages with
marked changes in the quantity or functional capacity of
mature effector cells. Although such perturbations often
carry lethal consequences for the mice, the defects in the
development of these particular blood lineages appear,
for the most part, to occur downstream of a lineage-com-
mitment checkpoint. For example, in the absence of the
erythroid-affiliated transcription factor GATA-1, mice
die of anaemia because mature oxygen-carrying red
blood cells do not form. Although erythroid commitment
is intact in these mice, erythroid lineage progression
stalls at the pro-erythroblast stage. From this kind of
experiment, GATA-1 would appear not to be required
for commitment to the erythroid lineage.
Forced or ectopic expression experiments provide a quite
different view from the knockout studies [5]. For
example, enforced expression of GATA-1 in a variety of
different non-committed haematopoietic cell lines has
been shown to result in apparent unilineage commitment
and differentiation. In the most striking of cases, the
levels of GATA-1 overexpression actually determine the
particular lineage produced. So knockout and misexpres-
sion experiments seem to lead to quite different conclu-
sions with regard to GATA-1 and commitment — is this a
potential paradox? Maybe not, but hold that thought: the
recent example of Pax5 may provide a plausible solution
to this particular conundrum.
Pax5 is a paired-domain transcription factor which,
within the haematopoietic system, is expressed exclu-
sively in the B-lymphocyte lineage. In the absence of
Pax5, B-lymphocyte lineage progression stalls at the pro-
B cell stage in vivo. Although Pax5-deficient pro-B cells
can be propagated in vitro under appropriate culture
conditions, that is, in the presence of interleukin-7 (IL-
7) and stromal cells, further progression down the B-lym-
phocyte lineage is prevented unless Pax5 is reintroduced
into the cells. On the face of it, this seems all too famil-
iar, just another lineage-affiliated transcription factor
that is important for completing the differentiation or
maturation programme, but not essential for commit-
ment to the lineage per se.
And that’s where it may all have ended if the Pax5-defi-
cient pro-B cell cultures, when left to their own devices,
had not eventually exhausted their supply of IL-7 [2].
While control B-lymphocyte cultures matured and died,
their Pax5-deficient counterparts survived, albeit in an
apparently transmuted form looking rather more like
myeloid than lymphoid cells. This was the proverbial
crack through which Busslinger and colleagues [2] drove
the wedge. By culturing Pax5-deficient pro-B cells under
appropriate conditions in the presence of cytokines that
drive the development of various different haematopoi-
etic lineages, a previously unimagined repertoire of
haematopoietic lineage potentials was revealed
(Figure 2). These pro-B cells could be entrained into
macrophage, dendritic cell, osteoclast, granulocyte and
natural killer cell fates in vitro. Most striking of all, when
introduced into T-cell deficient mice, Pax5-deficient
pro-B cells could reconstitute T-cell development in
vivo [3]. The apparent multipotentiality of Pax5-defi-
cient pro-B cells was confirmed by cell-cloning experi-
ments to be a property of individual cells. 
Some aspects of the plasticity of differentiation exhib-
ited by these Pax5-deficient pro-B cells have been previ-
ously hinted at in a variety of other studies of the early
B-lymphocyte compartment (see [6] and references
therein). Studies of normal and experimentally induced
leukaemias point to a close developmental connection
between B-lymphocyte and macrophage lineages, which
has been further supported by the identification of a
common B-lymphocyte–macrophage progenitor. Func-
tional experiments have further shown that certain
immortalised pre-B cell lines can be induced to trans-
differentiate into macrophages. Clearly the range of dif-
ferentiation potentials shown by these Pax5-deficient —
but otherwise normal — pro-B cells considerably ups the
ante and begs their comparison with bona fide
haematopoietic stem cells. But Pax5-deficient pro-B
cells have so far failed the most stringent of stem cell
tests — the ability to rescue the haematopoietic systems
of lethally irradiated mice. It would appear, therefore,
that these cells cannot differentiate down all the
haematopoietic lineage pathways in vivo, and so far have
also not been able to produce erythroid or megakary-
ocytic cells in vitro. Analysis of the molecular features of
these cells, however, reveals some striking similarities
with the stem/multipotential cell compartment [2]. 
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Figure 1
The lineage relationships of blood. Multiple blood lineages are
specified from a pool of self-renewing multipotential stem cells that
originally form from the embryonic mesoderm. Colours are used to
illustrate the idea that certain ‘components’ of all the different
possible downstream fates are simultaneously available at sub-
critical levels in multipotent stem cells. 
Neutrophil
Eosinophil
Mast cell
Megakaryocyte
Erythrocyte
Macrophage
T lymphocyte
Natural killer
Dendritic cell
Osteoclast
B lymphocyte
Differentiation
Mesoderm
Haematopoietic
stem cell
‘Inductive’
Dormancy
Self-renewal
‘Stochastic’
H
om
eo
st
as
is
O
nt
og
en
y
Current Biology
Apoptosis
It has been proposed that, under conditions of self-
renewal, multipotential haematopoietic progenitor cells
simultaneously prime several different lineage-affiliated
programs of gene activity [7]. This is apparent from the
level of chromatin accessibility of certain cis-regulatory
elements of lineage-affiliated loci and the low-level tran-
scription of candidate lineage regulators. One interpreta-
tion of these data is that multilineage priming provides a
ground-state level of multilineage ‘noise’, which in turn
provides multiple starting points for lineage-affiliated
circuits or ‘loops’ of gene activity that could have both
interactive and competitive properties [8]. This provides
a framework in which lineage specification could arise as
a simple threshold event that is probabilistic or stochastic
in nature. In such a scheme, unilineage commitment and
differentiation not only involves the consolidation of
appropriate programs of gene activity, but also requires
the repression of primed programs that are no longer
appropriate for differentiation down the lineage selected.
Molecular analysis of Pax5-deficient pro-B cells reveals
something of a reversion to this putatively ‘promiscuous’
molecular ground state of multipotential stem cells.
Thus in addition to B-cell-associated genes, Pax5-defi-
cient cells also express, to varying levels, genes charac-
teristic of other haematopoietic lineages. These include
myeloperoxidase and the macrophage colony-stimulat-
ing factor (M-CSF) receptor (myeloid-specific), the pre-
T-cell receptor α chain (T-cell-specific), perforin
(natural killer cell specific) and GATA-1. The low-level
activation of lineage-promiscuous expression presum-
ably provides the molecular framework from which
lineage fates can be extricated from the Pax5-deficient
pro-B cells. For example, the ability of these cells to
develop into monocytes in response to M-CSF is pre-
sumably due to their expression of M-CSF-receptor.
This promiscuity in gene expression is not observed in
wild-type pro-B cells and, importantly, is abolished in
Pax5-deficient cells when Pax5 expression is restored by
retroviral transduction.
These data also argue that the primary role of Pax5 in
commitment to the B-lymphocyte lineage lies in its
ability to repress other lineage options and perhaps
provide a potential solution to the GATA-1 conundrum
raised earlier: if the primary role for a transcription factor
in commitment is to close the door on other options, it
would most easily be scored functionally by misexpres-
sion. These new data also suggest that a re-investigation
of previously generated knockout mice for as yet
untested lineage potentials might be fruitful. Finally, it
is interesting to note that Pax5 is mono-allelically
expressed in early haematopoietic progenitors [9]. Math-
ematical modelling of haplo-insufficiency syndromes has
shown that expression of mono-allelically expressed
genes can readily result in large ‘spikes’ of protein
product levels [10]. Such a mechanism might underlie
the apparently stochastic nature of lineage specification
in haematopoiesis.
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Figure 2
Lineage potentials of Pax5-deficient pro-B cells. In the absence of
Pax5, pro-B cells cannot complete B-cell differentiation but, in the
presence of IL-7, can self-renew. IL-7-dependent self-renewal inhibits
alternative differentiation outcomes but, after withdrawal of IL-7, Pax5-
deficient pro-B cells can, under appropriate conditions, differentiate
down the various lineage pathways shown. Coloured sectors within
the Pax5-deficient pro-B-cell compartment indicate the various lineage-
affiliated programs of gene activity of which some components have
been detected. Given the information we have at present, there is not
complete parity between the lineage-affiliated programmes detected in
Pax5-deficient pro-B cells and their observed differentiation capacity,
although further molecular profiling and functional analysis of these
cells may well change this picture.
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